Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Grant or award Director acquired 2,886 shares (grant or award)
  2. 4 Grant or award Director acquired 3,406 shares (grant or award)
  3. 4/A Derivatives Options or other derivatives
  4. 4/A Derivatives Options or other derivatives
  5. 4/A Derivatives Options or other derivatives
  6. 4 Exercise or conversion President & CEO acquired 5,000 shares (option exercise)
  7. 4 Grant or award Director acquired 1,215 shares (grant or award)
  8. 4 Grant or award Director acquired 2,331 shares (grant or award)
  9. 4 Grant or award Director acquired 4,761 shares (grant or award)
  10. 4 Grant or award Director acquired 2,480 shares (grant or award)
  11. 4 Grant or award Director acquired 2,926 shares (grant or award)
  12. 4 Open-market buy President & CEO bought 582 shares at $4.81 ($2,799)
  13. 4 Open-market buy Chief Medical Officer bought 1,670 shares at $4.81 ($8,033)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 940 shares (grant or award)
  18. 4 Grant or award Director acquired 1,782 shares (grant or award)
  19. 4 Grant or award Director acquired 3,417 shares (grant or award)
  20. 4 Grant or award Director acquired 1,881 shares (grant or award)

Page 9 of 37 · 739 filings